This 10-cent heart drug cuts hospitalizations by 25%

Three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, and Peter van der Meer suggest that a low dose of the inexpensive heart failure drug digoxin may help patients avoid hospitalization and lower their risk of death. Heart failure, which affects over 500,000 people in the Netherlands, causes the heart to function inefficiently, leading to symptoms like severe shortness of breath and frequent hospital visits.

The drug, known for its centuries-long use and low cost at less than ten cents per day, may soon be a common treatment option due to these promising findings. Three UMCG studies published in journals such as Nature Medicine and JAMA support the potential benefits of digoxin as an additional heart failure treatment alongside the "Fantastic Four" standard medications.

The research, presented at the ESC Heart Failure Congress in Barcelona, found that patients taking digoxin experienced a 25% reduction in heart failure hospital admissions compared to those who received a placebo. While individual study results may not have reached statistical significance, a meta-analysis combining data from multiple studies confirmed the drug's efficacy.

A follow-up study of 288 patients showed the drug's safety and effectiveness during withdrawal, with 14 participants experiencing hospitalization or death. These findings could potentially lead to changes in heart failure guidelines, making digoxin accessible to more patients despite its low cost.